Inflammatory Biomarker Linked to Type 2 Diabetes Shows Increased Risk of Liver Cancer
Drug Topics
APRIL 14, 2025
Furthermore, C-reactive protein has greater prognosis for lung cancer, colorectal cancer, and ovarian cancer.
Mon.Apr 14, 2025
484 
STAT+: Attorneys general want Congress to prohibit PBMs from owning affiliated pharmacies
STAT
APRIL 14, 2025
Dozens of state attorneys general are urging Congress to pass a law prohibiting pharmacy benefit managers from simultaneously owning pharmacies, arguing such a move would boost competition and create more affordable prescription drug prices for Americans. Their concern is these arrangements create conflicts of interest that allow pharmacy benefits managers to dominate the design of health plans for tens of millions of Americans, and also distort the distribution and pricing for prescription medi
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Independent Pharmacies Must Be Prepared For DEA Inspections | AAP 2025
Drug Topics
APRIL 14, 2025
At AAP 2025, Ron Friedman discussed best practices for responding to a DEA inspection, how to identify any red flags, and best practices for dispensing.
Pharma’s capital allocation could shift as tariffs threaten an already fragile profit model
PharmaVoice
APRIL 14, 2025
Major changes to the dynamics of the pharmaceutical ecosystem are making executive decisions even tougher.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacists’ Expertise Can Improve Patient Outcomes in Transitions of Care
Drug Topics
APRIL 14, 2025
With transitions of care inclusive of multiple health care settings, each provider must play a specific role to ensure overall improved patient outcomes.
Community Pharmacies Actively Advance Clinical Trial Access
Pharmacy Times
APRIL 14, 2025
Collecting, analyzing, and interpreting data are pharmacist skills.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Pfizer discontinues its experimental GLP-1 pill
STAT
APRIL 14, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we discuss interesting new gene-editing data from Verve, see the NIH starting to convene advisory councils again, and more.
Accurate Online Education Crucial in Acne Management
Drug Topics
APRIL 14, 2025
Researchers explored TikToks role in the dissemination of information regarding isotretinoin and its users.
Kyowa Kirin constructs drug manufacturing facility in Japan
Pharmaceutical Technology
APRIL 14, 2025
Kyowa Kirin has concluded the construction of its new drug substance (DS) manufacturing facility, the HB7 building in Japan.
Study Finds COVID-19 Therapies Cause Few Serious Adverse Effects
Drug Topics
APRIL 14, 2025
However, patients should still be monitored for potential serious adverse effects, as investigators identified potential new concerns.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Approval moves Columvi earlier in DLBCL treatment pathway
pharmaphorum
APRIL 14, 2025
Roche has claimed a first-in-class approval in the EU for Columvi in relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data
Pharmaceutical Technology
APRIL 14, 2025
Phase Ib results show VERVE-102 reduced LDL-C levels with no serious safety issues, unlike Verves VERVE-101 programme.
BMS gets another FDA okay for Opdivo/Yervoy combo
pharmaphorum
APRIL 14, 2025
Bristol-Myers Squibb has claimed its second FDA approval in just a few days for its Opdivo/Yervoy combination, this time in liver cancer.
FDA Approves Vyvgart Hytrulo Prefilled Syringe With Self-Injection for Generalized Myasthenia Gravis, CIDP
Pharmacy Times
APRIL 14, 2025
The new indication expands administration methods for the combination of efgartigimod alfa and hyaluronidase-qvfc, which are already approved for the treatment of some immune-related conditions.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit
Pharmaceutical Technology
APRIL 14, 2025
Sandoz is suing Amgen over alleged patent abuse delaying the US launch of a biosimilar to the autoimmune drug Enbrel.
Why relying on AI outcome models may not be a good idea
pharmaphorum
APRIL 14, 2025
The use of AI outcome prediction models (OPMs) in medicine is on the rise, but a new paper has warned widespread use could lead to patient harm.
The Evolving Landscape of Polycythemia Vera Treatment
Pharmacy Times
APRIL 14, 2025
Current treatment strategies are aimed at reducing hematocrit and symptom burden through phlebotomy, aspirin, and cytoreductive agents, while emerging therapies offer promise for better disease control and quality of life.
Pfizer's weight-loss aspirations are dealt a heavy blow
pharmaphorum
APRIL 14, 2025
Pfizer has been forced to discontinue its oral GLP-1 receptor agonist danuglipron after seeing signs of liver toxicity in late-stage clinical testing.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Imlunestrant Plus Abemaciclib Improves Progression-Free Survival in Patients With ER+, HER2- Advanced Breast Cancer
Pharmacy Times
APRIL 14, 2025
Imlunestrant is an investigational, brain-penetrating, oral selective degrader of estrogen receptor.
How to fix pharma's content duplication problem
pharmaphorum
APRIL 14, 2025
Artificial intelligence, particularly advanced natural language processing (NLP), offers a potential solution to duplication through what can be described as "intelligent content adaptation"
Study Finds Adverse Pregnancy Outcomes Mediate Association With CVD Risk, Prepregnancy Obesity in Midlife
Pharmacy Times
APRIL 14, 2025
Promoting weight management prior to pregnancy and in early life may yield stronger cardiovascular and maternal health.
An AI-Pharma Transport Collaboration
Pharmaceutical Commerce
APRIL 14, 2025
How artificial intelligence tools are helping to optimize the pharmaceutical transport process.
Preventing Drug Diversion in Pharmacy Settings: Best Practices, DEA Regulations, and Comprehensive Security Strategies
Pharmacy Times
APRIL 14, 2025
Expert provides a comprehensive overview of drug diversion prevention in pharmacy settings.
FDA Grants Full Approval to Opdivo Plus Yervoy Regimen for Unresectable or Metastatic Hepatocellular Carcinoma
PharmExec
APRIL 14, 2025
Approval of Opdivo plus Yervoy combination was based on results from the Phase III CheckMate-9DW trial, which demonstrated significantly improved overall survival and overall response rate in patients with unresectable or metastatic hepatocellular carcinoma.
Driving Clinical Pharmacy Development With Data-Driven Metrics and Insights
Pharmacy Times
APRIL 14, 2025
There are no clearly defined, widely accepted clinical pharmacist metrics.
Odylia Rare Disease Day Event Highlights Challenges in R&D for Orphan Drugs
PharmExec
APRIL 14, 2025
Odylia Therapeutics event brings together leaders across biotech, pharma, venture capital, patient advocacy, and research sectors to address the financial and structural barriers that impede rare disease drug development.
Pfizer drops obesity pill development after liver injury report
Pharmaceutical Technology
APRIL 14, 2025
Pfizer still has another obesity pill in development, PF-07976016, which is currently in a Phase IIa trial.
The Role of CDMOs in the Pharma Cold Chain Machine
Pharmaceutical Commerce
APRIL 14, 2025
Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.
COPD market projected to grow to $30.2bn in the 7MM by 2033
Pharmaceutical Technology
APRIL 14, 2025
The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) is forecast to grow from $11.6bn in 2023 to $30.2bn by 2033, representing a compound annual growth rate of 10%, according to leading data and analytics company GlobalData.
The Complexity of Healthcare Price Transparency
Pharmaceutical Commerce
APRIL 14, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris ODell, Turquoise Healths SVP of market solutions, discusses the biggest challenges healthcare organizations currently face in terms of price transparency.
Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial
Pharmaceutical Technology
APRIL 14, 2025
Additional melanoma patients will have access to Scancells DNA vaccine as part of an ongoing clinical trial.
“Data is our currency” – with Gingko Bioworks’ John Androsavich
pharmaphorum
APRIL 14, 2025
Data is our currency with Gingko Bioworks John Androsavich Sara.
LogiPharma Europe 2025: Driving Innovation in Core Therapeutic Areas
Pharmaceutical Commerce
APRIL 14, 2025
Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.
Let's personalize your content